The FDA and the Company have agreed to meet in-person on January 31, 2019 to discuss this matter. Remoxy is the proposed trade name for a new type
The post Pain Therapeutics challenges FDA decision on Remoxy appeared first on Pharma Business review.
Original Article: Pain Therapeutics challenges FDA decision on Remoxy